Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 32,387 articles published since 2008
|||| 50 

These are the 32387 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
226 Editorial Portal-vein blood samples as a new diagnostic entity for pancreatic cancer. 2016

Chapman, Christopher G / Waxman, Irving. ·a Center for Endoscopic Research and Therapeutics (CERT) , The University of Chicago Medicine and Biological Sciences , Chicago , IL , USA. ·Expert Rev Gastroenterol Hepatol · Pubmed #27077275.

ABSTRACT: -- No abstract --

227 Editorial [Pancreatic lesions]. 2016

Delorme, S / Helmberger, T. ·Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland. s.delorme@dkfz-heidelberg.de. · Institut für Diagnostische und Interventionelle Radiologie, Neuroradiologie und Nuklearmedizin, Städtisches Klinikum München, Klinikum Bogenhausen, Englschalkinger Straße 77, 81925, München, Deutschland. ·Radiologe · Pubmed #27000275.

ABSTRACT: -- No abstract --

228 Editorial Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients? 2016

Park, Hee Chul. ·Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ·Gut Liver · Pubmed #26934882.

ABSTRACT: -- No abstract --

229 Editorial Pancreatic Cancer: Current Progress and Future Challenges. 2016

Hussain, S Perwez. ·Head Pancreatic Cancer Unit, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institutes, NIH, Bethesda, MD 20892, USA. ·Int J Biol Sci · Pubmed #26929733.

ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, remains one of the highly lethal malignancies. The highly refractory nature of clinically advanced disease and lack of a reliable biomarker for early detection are major obstructions in improving patient outcome. The recent efforts, however, in understanding the pancreatic tumor biology have resulted in the recognition of novel addictions as well as vulnerabilities of tumor cells and are being assessed for their clinical potential. This special issue highlights some of the recent progress, complexity and challenges towards improving disease outcome in patients with this lethal malignancy.

230 Editorial The safety of incretin based drug treatments for type 2 diabetes. 2016

Bolen, Shari D / Maruthur, Nisa M. ·Division of General Internal Medicine, Department of Medicine, The MetroHealth System/Case Western Reserve University, Cleveland, OH, USA Department of Epidemiology and Biostatistics, Case Western Reserve University sdb73@case.edu. · Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, MD, USA. ·BMJ · Pubmed #26888024.

ABSTRACT: -- No abstract --

231 Editorial Any progress in pancreatic cancer? 2016

Glimelius, Bengt. ·a Department of Immunology, Genetics and Pathology , Uppsala University , Uppsala , Sweden. ·Acta Oncol · Pubmed #26883020.

ABSTRACT: -- No abstract --

232 Editorial Partnering to advance early detection and prevention efforts for pancreatic cancer: the Florida Pancreas Collaborative. 2016

Permuth, Jennifer B / Trevino, Jose / Merchant, Nipun / Malafa, Mokenge / Anonymous50858. ·Department of Cancer Epidemiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Gastrointestinal Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Surgery, Division of General Surgery, University of Florida Health Sciences Center, Gainesville, FL, USA. · Department of Surgery, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA. ·Future Oncol · Pubmed #26863203.

ABSTRACT: -- No abstract --

233 Editorial Androgen-deprivation therapy and pancreatic β-cell dysfunction in men. 2016

Mauvais-Jarvis, Franck. ·Section of Endocrinology & Metabolism, Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70112, USA. Electronic address: fmauvais@tulane.edu. ·J Diabetes Complications · Pubmed #26861947.

ABSTRACT: -- No abstract --

234 Editorial Genomic Testing for Gemcitabine-Based Treatment of Pancreatic Cancer. 2016

Zhang, Jianliang / Hochwald, Steven N. ·Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY (JZ, SNH). · Department of Surgical Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY (JZ, SNH). steven.hochwald@roswellpark.org. ·J Natl Cancer Inst · Pubmed #26857393.

ABSTRACT: -- No abstract --

235 Editorial How can next-generation diagnostics aid pancreatic adenocarcinoma treatment? 2016

Zhang, Shuang Qin / Catenacci, Daniel V T. ·Department of Medicine, Section of Hematology & Oncology, University of Chicago, Chicago, IL 60637, USA. ·Future Oncol · Pubmed #26831761.

ABSTRACT: -- No abstract --

236 Editorial Pre-invasive intraductal papillary neoplasm of the pancreatobiliary system. 2016

Nakanuma, Yasuni. ·Department of Diagnostic Pathology, Shizuoka Cancer Center, Sunto-Nagaizumi 1007, 411-8777 Shizuoka, Japan. Electronic address: nakanuma@staff.kanazawa-u.ac.jp. ·Clin Res Hepatol Gastroenterol · Pubmed #26774364.

ABSTRACT: -- No abstract --

237 Editorial Get Ready to Meet the Growing Demand From Patients With Pancreatic Cysts. 2016

Othman, Mohamed O / Buscaglia, Jonathan M. ·Gastroenterology and Hepatology Section, Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Division of Gastroenterology and Hepatology, Department of Medicine, Stony Brook University School of Medicine, Stony Brook, New York. ·Clin Gastroenterol Hepatol · Pubmed #26713890.

ABSTRACT: -- No abstract --

238 Editorial Endoscopic ultrasonography for pancreatic cystic lesions: let's enhance it. 2016

Polkowski, Marcin. ·Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Centre for Postgraduate Education, Warsaw, Poland, and Department of Gastroenterological Oncology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. ·Endoscopy · Pubmed #26710279.

ABSTRACT: -- No abstract --

239 Editorial A Cutoff of 2 cm Instead of 3 cm Would Detect More Malignant BD-IPMNs: Is There a Reason to Be Wary of the International Consensus Guidelines? 2016

Hines, O Joe / Stark, Alexander P. ·Department of Surgery, University of California Los Angeles, Los Angeles, CA. ·Pancreas · Pubmed #26658036.

ABSTRACT: -- No abstract --

240 Editorial New strategies for the early detection of pancreatic cancer. 2016

Petrone, Maria Chiara / Arcidiacono, Paolo Giorgio. ·a Pancreato-Biliary Endoscopy and Endosonography Division, San Raffaele Scientific Institute , Vita Salute San Raffaele University , Milan , Italy. ·Expert Rev Gastroenterol Hepatol · Pubmed #26582179.

ABSTRACT: Pancreatic cancer (PC) remains a deadly disease and early detection through screening is likely to be our best hope to improve survival. Considering the low incidence of PC, population-based screening is not feasible, but is advisable for high-risk patients. Screening individuals at high risk for developing PC leads to the detection of premalignant lesions. High-grade pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm are the targets for early detection of PC. Endoscopic ultrasound (EUS) and magnetic resonance imaging are considered the most accurate techniques for pancreatic imaging; in particular EUS has emerged as a promising imaging test given its potential for tissue sampling to obtain diagnosis and to provide material for molecular profiling of PC. At the moment, screening should be performed within research protocols at experienced centers with a specific clinical and research interest, where a multidisciplinary team of specialists is available.

241 Editorial Editorial: Pancreatic neuroendocrine tumors: Primum non nocere. 2016

Chabot, John. ·Columbia University, New York, NY. Electronic address: jac4@columbia.edu. ·Surgery · Pubmed #26531234.

ABSTRACT: -- No abstract --

242 Editorial Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Gastrointestinal and Pancreatic Tumors: Is Negative Pressure Helpful or Does It Suck? 2016

Kawakami, Hiroshi / Kubota, Yoshimasa / Sakamoto, Naoya. ·Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan. hiropon@med.hokudai.ac.jp. · Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan. ·Dig Dis Sci · Pubmed #26462486.

ABSTRACT: -- No abstract --

243 Editorial The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA. 2016

Gleeson, Ferga C / Levy, Michael J. ·Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. ·Gastrointest Endosc · Pubmed #26227930.

ABSTRACT: -- No abstract --

244 Editorial MiRNAs as biomarkers of high-risk pancreatic cysts: a possible holy grail for the early detection of pancreatic cancer. 2015

Permuth, Jennifer B / Georgeades, Christina / Malafa, Mokenge. ·Department of Cancer Epidemiology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Morsani College of Medicine, University of South Florida, Tampa, FL, USA. ·Future Oncol · Pubmed #26549701.

ABSTRACT: -- No abstract --

245 Editorial Ask someone who cares: Caregiver surveys as a means of improving the management of pancreatic cancer patients. 2015

Turner, Richard C. ·University of Tasmania, School of Medicine, Australia. Electronic address: richard.turner@utas.edu.au. ·Pancreatology · Pubmed #26547593.

ABSTRACT: -- No abstract --

246 Editorial A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling. 2015

Cowan, Robert W / Maitra, Anirban / Rhim, Andrew D. ·Division of Gastroenterology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. · Departments of Pathology and Translational Molecular Pathology, Sheikh Ahmed Pancreatic Cancer Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Gastroenterology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: arhim@med.umich.edu. ·Gastroenterology · Pubmed #26526714.

ABSTRACT: -- No abstract --

247 Editorial Prediction in pancreatic cancer. 2015

Wylie, Neil / Koea, Jonathan B. ·Department of Surgery, North Shore Hospital, Auckland, New Zealand. ·ANZ J Surg · Pubmed #26498563.

ABSTRACT: -- No abstract --

248 Editorial Advanced pancreatic cancer - how to choose an adequate treatment option. 2015

Korkeila, Eija A. ·Eija A Korkeila, Department of Oncology, Turku University Hospital and University of Turku, 20521 Turku, Finland. ·World J Gastroenterol · Pubmed #26478662.

ABSTRACT: The prognosis of pancreatic adenocarcinoma is poor, making it one of the leading causes of cancer-related death. The 5-year overall survival rate remains below 5% and little progress is made during the past decade. Only about 10%-20% of patients are eligible for curative-intent surgery and the majority end up having recurring disease even after radical surgery and postoperative adjuvant chemotherapy. Chemotherapy in metastatic disease is palliative at best, aiming at disease and symptom control and prolongation of life. Treatment always causes side effects, the degree of which varies from patient to patient, depending on the patient's general condition, concomitant morbidities as well as on the chosen treatment modality. Why is pancreatic cancer so resistant to treatment? How to best help the patient to reach the set treatment goals?

249 Editorial Pancreatic EUS: the linear strikes back. 2015

Petrone, Maria Chiara / Arcidiacono, Paolo Giorgo. ·Endosonography Unit, Gastroenterology and Gastrointestinal Endoscopy Unit, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy. · Gastrointestinal Endoscopy Unit, Gastroenterology and Gastrointestinal Endoscopy Unit, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy. ·Gastrointest Endosc · Pubmed #26471999.

ABSTRACT: -- No abstract --

250 Editorial Better Biomarkers for Pancreatic Diseases. 2015

Whitcomb, David C. ·From the Departments of Medicine, Cell Biology & Molecular Physiology, and Human Genetics, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh/UPMC, Pittsburgh, PA. ·Pancreas · Pubmed #26465944.

ABSTRACT: -- No abstract --

Back · Next